房水病毒载量定量预测急性视网膜坏死视力预后不良
该研究回顾性分析148例急性视网膜坏死(ARN)患者,其中73例有房水病毒DNA定量数据。结果显示水痘-带状疱疹病毒占84.5%,房水病毒DNA拷贝数越高、视网膜受累象限越多,最终最佳矫正视力越差。定量病毒载量评估可能有助于风险分层和及时选择干预措施。
要点
- 房水病毒DNA拷贝数越高,ARN患者最终BCVA越差(p<0.001)。
- 视网膜受累象限越多,最终BCVA越差(p<0.0001)。
- 从症状出现到启动抗病毒治疗的时间与最终BCVA仅呈弱且非显著趋势(p=0.055)。
核心结论
- 在ARN大样本单中心队列中,较高的房水病毒载量和较大的视网膜受累范围与较差的视力结局相关。
- 就诊时定量病毒载量评估可能支持风险分层和及时选择最佳干预措施。
研究设计与样本
- 回顾性连续病例系列,纳入1985年至2021年三级转诊中心治疗的148例ARN患者。
- 通过PCR确定致病病毒及就诊时房水病毒DNA拷贝数,其中73例有定量房水病毒载量数据。
- 分析最终最佳矫正视力(BCVA,logMAR)与房水病毒载量、抗病毒启动时机及视网膜坏死范围(受累象限)的关联。
主要发现
- 水痘-带状疱疹病毒占125/148例(84.5%),单纯疱疹病毒1型占16例(10.8%),2型占7例(4.7%)。
- 平均发病年龄50.8岁;从症状出现到启动抗病毒治疗的平均间隔为11.5±7.0天;从发病到玻璃体切除术的中位间隔为22天。
- 平均BCVA从就诊时0.71 logMAR恶化至末次随访时1.20 logMAR(p<0.0001)。
- 较高的房水病毒DNA拷贝数与较差的最终BCVA相关(p<0.001)。
- 较大的视网膜受累范围(更多象限受累)也与较差的最终BCVA相关(p<0.0001)。
关键数值与推荐
- 房水病毒DNA拷贝数越高,最终BCVA越差(p<0.001)。
- 视网膜受累象限越多,最终BCVA越差(p<0.0001)。
- 从发病到启动抗病毒治疗的间隔与最终BCVA呈弱且非显著趋势(p=0.055)。
临床怎么用
- 就诊时进行房水定量病毒载量检测可能有助于对ARN患者进行风险分层。
- 病毒载量高和视网膜受累范围广提示视力预后较差,可支持及时选择最佳干预措施。
局限性
- 回顾性单中心设计。
- 仅73/148例患者有定量房水病毒载量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Acute retinal necrosis (ARN) is a rare herpetic uveoretinitis that frequently results in severe vision loss. Evidence from large single-centre cohorts remains limited. We evaluated clinical characteristics and prognostic factors in 148 ARN cases. METHODS: We retrospectively reviewed 148 consecutive patients with ARN treated at a tertiary referral centre (1985-2021). Causative virus and aqueous viral DNA copy number at presentation were determined by PCR. Associations of final best-corrected visual acuity (BCVA, logMAR) with aqueous viral load, timing of antiviral initiation and extent of retinal necrosis (quadrants involved) were analysed. Quantitative aqueous viral-load data were available in 73 of 148 patients. RESULTS: Varicella-zoster virus accounted for 125/148 (84.5%) cases; herpes simplex virus (HSV-1) for 16 (10.8%) and HSV-2 for 7 (4.7%). Mean age at onset was 50.8 years. Mean interval from symptom onset to antiviral initiation was 11.5±7.0 days; median interval from onset to vitrectomy was 22 days. Mean BCVA worsened from 0.71 logMAR at presentation to 1.20 logMAR at final visit (p<0.0001). Higher aqueous viral DNA copy number correlated with poorer final BCVA (p<0.001). Greater retinal involvement (more quadrants affected) was also associated with poorer final BCVA (p<0.0001). The interval from onset to antiviral initiation showed a weak, non-significant trend with final BCVA (p=0.055). CONCLUSIONS: In this large single-centre cohort of ARN, higher aqueous viral load and greater retinal involvement were associated with worse visual outcome. Quantitative viral load assessment at presentation may support risk stratification and timely selection of optimal interventions.
引用
- Tsubota K, Nonaka R, Asakage M, et al. Quantitative aqueous PCR viral load predicts poor visual outcome in acute retinal necrosis. Br J Ophthalmol. 2026. PMID: 41986092. doi:10.1136/bjo-2026-329493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。